The Pharmacy Times® IVIG Resource Center is a comprehensive resource for clinical news and expert insights on the use of intravenous immunoglobulin, a product comprised of antibodies administered intravenously.
March 11th 2024
The IVIG therapies were previously approved for 4-week room temperature storage conditions of 25º Celsius during the first 24 months of shelf life.
Turning Food Allergy Triggers Into Therapy: A Managed Care Lens on Immunotherapy and Targeted Biologics
1.5 Credits / Immunology
View More
Individualizing Care for Patients With PIDD: The Role of the Pharmacist in Managing Patients on IVIg and SCIg
1.5 Credits / Immunology
View More
Understanding the Role of IVIg and SCIg for the Management of CIDP: Information the Pharmacist Needs to Know to Optimize Care, featuring a Patient Perspective
1.5 Credits / Immunology, Neurology
View More
Targeted Therapies for the Management of Eosinophilic Esophagitis Across the Life Cycle: The Role of the Pharmacist in Patient Identification and Optimization, featuring a Pat...
1.5 Credits / Immunology
View More
Discerning the Significant Burden of Prurigo Nodularis: The Role of Targeted Therapies in Improving Patient Quality of Life, featuring a Patient Perspective
1.5 Credits / Dermatology, Immunology
View More
Reducing the Clinical and Economic Burden of Managing CRSwNP With Emerging Targeted Therapies: A Review for Specialty Pharmacists, featuring a Patient Perspective
1.5 Credits / Immunology
View More
Reducing the Clinical and Caregiver Burden of Moderate to Severe Pediatric Atopic Dermatitis Through Improved Access to Treatments, featuring a Caregiver Perspective
1.5 Credits / Dermatology, Immunology
View More
Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns
1.0 Credit / Law
View More
Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications
1.5 Credits / Law, Oncology
View More
Exploring Targeted Treatment Options for Hereditary Angioedema: Considerations for Pharmacists
1.0 Credit / Immunology
View More
Unveiling the Impact of Childhood Eczema: A Guide to Moderate-Severe Pediatric Atopic Dermatitis
1.0 Credit / Dermatology, Immunology
View More
Revolutionizing Pediatric Atopic Dermatitis Treatment With Targeted Biologics
1.0 Credit / Dermatology, Immunology
View More
Practical Approaches in the Management of Primary Immunodeficiency Disorders: Understanding the Role of Intravenous and Subcutaneous Immunoglobulin
1.0 Credit / Immunology, Rare Diseases
View More
Maximizing the Potential of Biologics in Moderate to Severe Pediatric Atopic Dermatitis: The Expertise of the Specialty Pharmacist
1.0 Credit / Dermatology, Immunology
View More
Managed Care Perspectives on the Burden of Food Allergies and Advances in Treatment
1.5 Credits / Allergy, Immunology
View More
Best Practices for Optimizing Biologic Therapy Management for Moderate to Severe Atopic Dermatitis in Children
1.5 Credits / Dermatology, Immunology
View More
Integrating Biologic Therapy Into Clinical Practice for the Management of Eosinophilic Esophagitis
1.5 Credits / Gastroenterology, Immunology
View More
Understanding the Burden of Eosinophilic Esophagitis in Children
1.0 Credit / Gastroenterology, Immunology
View More
The Expertise of the Specialty Pharmacist in Pediatric Eosinophilic Esophagitis
1.0 Credit / Gastroenterology, Immunology
View More
Child Abuse: Responsibilities and Protection of the Reporter
1.0 Credit / Law
View More
Emerging Biologic Therapy for the Management of Eosinophilic Esophagitis in Children
1.0 Credit / Gastroenterology, Immunology
View More
Optimizing Inflammatory Bowel Disease Treatment: A Pharmacist's Guide to Biologics and Monoclonal Antibodies
1.0 Credits / Gastroenterology, Immunology
View More
Navigating the Complexities of Biologic Therapy for Moderate to Severe Atopic Dermatitis in Children: The Impact of Pharmacists on Patient Care
1.5 Credit / Dermatology, Immunology
View More
IVIG, Steroids for Multisystem Inflammatory Syndrome in Children Have Varying Outcomes
November 16th 2022Despite an apparent benefit of intravenous immunoglobulin (IVIG) on early discharge, the likelihood of needing second-line treatment was 3 times higher in patients who initiated treatment with IVIG alone.
Read More
Effective Treatment for Some Patients with Arndt-Gottron Syndrome Can Be Achieved With IVIG
September 1st 2022Though there is no well-defined therapeutic approach to the treatment of Arndt-Gottron syndrome, intravenous immunoglobulins have been documented as a well-tolerated treatment in some cases.
Read More
Study: Metronidazole Desensitization Effectively Treats Patients with Hypersensitivity Reactions
August 1st 2022Patients with past medical histories of immunoglobulin E-mediated hypersensitivity reactions to metronidazole and other antimicrobial agents may receive safe and effective treatment using desensitization protocols.
Read More
Daily Medication Pearl: Privigen Immune Globulin Intravenous (Human)
July 22nd 2022Privigen is indicated for the treatment of primary humoral immunodeficiency, chronic immune thrombocytopenic purpura in patients 15 years of age and older, chronic inflammatory demyelinating polyneuropathy in adults.
Read More
Patients with Suspicion of Systemic Disease Require Ongoing Follow-Up for Diagnosis
July 14th 2022A recent case report detailing multiple procedures and inconclusive biopsies underwent by a patient with unusual presentation of immunoglobulin G4-related disease before conclusive diagnosis emphasizes the importance of follow-up with patients with suspicion of systemic disease.
Read More
Investigators Report Series of Substates that Reprogram IgG to 1-Step Synthesis of gsADCs
June 20th 2022Glycosite-specific antibody‒drug conjugates (gsADCs), harnessing Asn297 N-glycan of IgG Fc as the conjugation site for drug payloads, usually require multi-step glycoengineering with 2 or more enzymes, which limits the substrate diversification and complicates the preparation process.
Read More
Drug Sequestration in the Management of Patients with Extracorporeal Membrane Oxygenation Support
June 8th 2022Dosing recommendations for patients requiring ECMO support are unlikely to be supported by high-quality evidence, but are usually extrapolated from the physicochemical characteristics of individual drugs in conjunction with data from pharmacokinetic studies and case reports.
Read More